Sohn Claira, Ma Jiacheng, Ray William J, Frost Bess
Department of Cell Systems and Anatomy, Barshop Institute for Longevity and Aging Studies, Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health San Antonio, San Antonio, TX, United States.
The Neurodegeneration Consortium, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Front Aging. 2023 Jan 23;4:1058968. doi: 10.3389/fragi.2023.1058968. eCollection 2023.
Neurodegenerative tauopathies, including Alzheimer's disease, are pathologically defined by the presence of aggregated forms of tau protein in brains of affected individuals. Previous studies report that the negative effects of pathogenic tau on the actin cytoskeleton and microtubules cause a toxic destabilization of the lamin nucleoskeleton and formation of nuclear invaginations and blebs. Based on the known function of the nucleus as a mechanosensor, as well as the high incidence of nuclear pleomorphism in human Alzheimer's disease and related tauopathies, we investigated the effects of pathogenic tau on nuclear tension. We first find that tau-dependent nuclear envelope invagination and relocalization of LInker of Nucleoskeleton and Cytoskeleton (LINC) complex components are conserved in a newly-developed neuroblastoma cell line that features doxycycline-inducible expression of a tau mutant associated with autosomal dominant frontotemporal dementia. We next determine that a Förster resonance energy transfer (FRET)-based sensor of nuclear tension responds to cytoskeletal stabilization and destabilization when expressed in neuroblastoma cells. Using this nuclear tension sensor, we find that induced expression of pathogenic tau is sufficient to decrease nuclear tension. This work provides the initial proof-of-concept evidence that pathogenic forms of tau alter nuclear tension, paving the way for the future study of altered nuclear mechanosensing in the context of tau-mediated neurodegenerative disorders.
神经退行性tau蛋白病,包括阿尔茨海默病,在病理学上的定义是受影响个体大脑中存在聚集形式的tau蛋白。先前的研究报告称,致病性tau蛋白对肌动蛋白细胞骨架和微管的负面影响会导致核纤层核骨架的毒性不稳定,并形成核内陷和核泡。基于细胞核作为机械传感器的已知功能,以及人类阿尔茨海默病和相关tau蛋白病中核多形性的高发生率,我们研究了致病性tau蛋白对核张力的影响。我们首先发现,在一种新开发的神经母细胞瘤细胞系中,tau蛋白依赖性核膜内陷和核骨架与细胞骨架连接复合体(LINC)成分的重新定位是保守的,该细胞系具有强力霉素诱导表达与常染色体显性额颞叶痴呆相关的tau突变体的特征。接下来,我们确定一种基于Förster共振能量转移(FRET)的核张力传感器在神经母细胞瘤细胞中表达时,会对细胞骨架的稳定和不稳定做出反应。使用这种核张力传感器,我们发现致病性tau蛋白的诱导表达足以降低核张力。这项工作提供了初步的概念验证证据,即致病性tau蛋白形式会改变核张力,为未来在tau介导的神经退行性疾病背景下研究改变的核机械传感铺平了道路。